Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.67 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.67 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.67 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.65 |
| ▸ | MAOA | P21397 | 2/20 | 0.65 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.65 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.65 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.65 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27560699 | 1.00 | TAAR1 (0.67) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL27852110 | 1.00 | TAAR1 (0.67) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL27637944 | 1.00 | TAAR1 (0.67) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL10872755 | 0.92 | TAAR1 (0.76) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL10872752 | 0.92 | TAAR1 (0.76) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL9417738 | 0.91 | TAAR1 (0.75) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL9468040 | 0.91 | TAAR1 (0.57) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL4075991 | 0.91 | TAAR1 (0.75) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL17413364 | 0.91 | TAAR1 (0.75) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL20714984 | 0.89 | SLC6A2 (0.88) | TAAR1SLC6A2SLC6A3SLC6A4MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111183219-B | Methods and compositions for performing living cell analysis of intracellular ATP | 赛多利斯生物分析仪器有限公司 | 2024-02-20 | — | — | CN | disclosed |
| EP-3631000-A1 | RAPID SAMPLE TEMPERATURE CHANGING FOR ASSAYING | Essenlix Corporation (US) | 2020-04-08 | — | — | EP | disclosed |
| WO-2018217953-A1 | RAPID SAMPLE TEMPERATURE CHANGING FOR ASSAYING | ESSENLIX CORPORATION (US) | 2018-11-29 | — | — | WO | disclosed |
| WO-2018148342-A1 | COMPRESSED OPEN FLOW ASSAY AND USE | ESSENLIX CORPORATION (US) | 2018-08-16 | — | — | WO | disclosed |
| EP-3338078-A1 | ASSAY DEVICE | Molecular Vision Limited (GB) | 2018-06-27 | — | — | EP | disclosed |
| EP-3338079-A1 | OPTICAL DETECTION UNIT | Molecular Vision Limited (GB) | 2018-06-27 | — | — | EP | disclosed |
| WO-2017029523-A1 | ASSAY DEVICE | MOLECULAR VISION LIMITED (GB) | 2017-02-23 | — | — | WO | disclosed |
| WO-2017029525-A1 | ASSAY DEVICE | MOLECULAR VISION LIMITED (GB) | 2017-02-23 | — | — | WO | disclosed |
| WO-2017029526-A1 | ASSAY DEVICE | MOLECULAR VISION LIMITED (GB) | 2017-02-23 | — | — | WO | disclosed |
| WO-2017029524-A1 | OPTICAL DETECTION UNIT | MOLECULAR VISION LTD (GB) | 2017-02-23 | — | — | WO | disclosed |
| WO-2013059648-A1 | 2,3,5 TRISUBSTITUTED ARYL AND HETEROARYL AMINO DERIVATIVES, COMPOSITIONS, AND METHODS OF USE | NEUROTHERAPEUTICS PHARMA, INC. (US) | 2013-04-25 | — | — | WO | disclosed |
| EP-1333828-B1 | PREVENTION OF DEVELOPMENT OF DYSKINESIAS | ORION CORP (FI) | 2008-07-02 | — | — | EP | disclosed |
| WO-2006124913-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEMS | NEUROTHERAPEUTICS PHARMA LLC (US) | 2006-11-23 | — | — | WO | disclosed |
| US-20060025387-A1 | Compositions and methods for the treatment of disorders of the central and peripheral nervous systems | CYTOSCAN SCIENCES LLC (US) | 2006-02-02 | — | — | US | disclosed |
| US-20040039041-A1 | Prevention of development of dyskinesias | ORION CORPORATION (FI) | 2004-02-26 | — | — | US | disclosed |
| EP-1333828-A2 | PREVENTION OF DEVELOPMENT OF DYSKINESIAS | ORION CORPORATION (FI) | 2003-08-13 | — | — | EP | disclosed |
| US-20020115703-A1 | Prevention of development of dyskinesias | ORION CORPORATION (FI) | 2002-08-22 | — | — | US | disclosed |
| WO-2002039991-A2 | PREVENTION OF DEVELOPMENT OF DYSKINESIAS | ORION CORPORATION (FI) | 2002-05-23 | — | — | WO | disclosed |
| US-5328828-A | Immunoassay for amphetamines with antibodies for conjugation and enzymes | SYNTEX (U.S.A.) INC. (US) | 1994-07-12 | — | — | US | disclosed |
| US-5135863-A | Immunoassay; drug abuse | SYNTEX (U.S.A.) INC. (US) | 1992-08-04 | — | — | US | disclosed |